Concepedia
Statistics
Publications
8
Citations
368
H-Index
Active since
1991
Affiliations
Vrije Universiteit Amsterdam(Current)
The Netherlands Cancer Institute
Evelien Smitskamp-Wilms is an author at Vrije Universiteit Amsterdam specializing in chemotherapy, medicine, and oncology.
Publications per year
1991–1999
Preclinical combination therapy with gemcitabine and mechanisms of resistance.
Godefridus J. Peters, Veronique W.T. Ruiz van Haperen, Andries M. Bergman et al. · PubMed · 1996 · 83 citations
Medicine, Pharmacology, Pharmacotherapy +9
Hydroxynitrile lyases from almond and sorghum as biocatalysts
Evelien Smitskamp-Wilms, Johannes Brussee, A. VAN DER GEN et al. · Recueil des Travaux Chimiques des Pays-Bas · 1991 · 66 citations
Life Sciences, Biochemistry, Plant Sciences +11
DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?
Evelien Smitskamp-Wilms, Giuseppe Giaccone, HM Pinedo · British Journal of Cancer · 1995 · 63 citations
Medicine, Cancer Biology, Oncology +10
Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression
Evelien Smitskamp-Wilms, Godefridus J. Peters, Herbert M. Pinedo et al. · Biochemical Pharmacology · 1994 · 37 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +6
Postconfluent multilayered cell line cultures for selective screening of gemcitabine
Evelien Smitskamp-Wilms, Herbert M. Pinedo, G. Veerman et al. · European Journal of Cancer · 1998 · 37 citations
Engineering, Cell Biology, Chemotherapy +11
1–5 of 8